On <scp>TRacK</scp> With Larotrectinib in a Neonate With a Giant Congenital <i>ETV6::NTRK3</i> Fusion‐Positive Infantile Fibrosarcoma of the Head and Neck
This case illustrates an example of pediatric precision oncology in a neonate with an ETV6::NTRK3 (+) congenital IFS of the head and neck region and provides further reference for the use of larotrectinib in the neonatal period.
Authors
- Maja Hühns (ORCID: https://orcid.org/0000-0003-3911-8754)
- Manfred Ballmann (ORCID: https://orcid.org/0000-0003-4480-1312)
- Claudia Bierwirth
- Friederike Terpe
- Teresa M. Cardesa‐Salzmann (ORCID: https://orcid.org/0000-0003-2142-6898)
- Stefanie Märzheuser
- Björn Schneider (ORCID: https://orcid.org/0000-0002-0282-7330)
- Monika Sparber‐Sauer (ORCID: https://orcid.org/0000-0001-9551-2399)
- Andreas Erbersdobler (ORCID: https://orcid.org/0000-0003-2624-7362)
- Christian Spang
- André Jakob
- Carl Friedrich Classen
- Christina Hauenstein
- Dorothea Stalmann
- Peter Hingst
Institutions
- Universitätsmedizin Rostock (DE)
- Klinikum Stuttgart (DE)
Publication Details
- Journal
- Head & Neck
- Published
- 2024-12-30
- DOI
- https://doi.org/10.1002/hed.28058
- Citations
- 1
- Primary Topic
- Sarcoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.42